MediPal Holdings Corporation (TYO:7459)
2,530.00
-18.50 (-0.73%)
Oct 1, 2025, 3:30 PM JST
MediPal Holdings Market Cap
MediPal Holdings has a market cap or net worth of 520.52 billion as of October 1, 2025. Its market cap has decreased by -4.30% in one year.
Market Cap
520.52B
Enterprise Value
414.88B
Revenue
3.71T
Ranking
n/a
PE Ratio
12.88
Stock Price
2,530.00
Market Cap Chart
Since June 30, 1999, MediPal Holdings's market cap has increased from 47.56B to 520.52B, an increase of 994.44%. That is a compound annual growth rate of 9.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 524.33B | 5.92% |
Dec 30, 2024 | 495.03B | 2.54% |
Dec 29, 2023 | 482.78B | 32.07% |
Dec 30, 2022 | 365.54B | -19.21% |
Dec 30, 2021 | 452.47B | 11.20% |
Dec 30, 2020 | 406.91B | -19.69% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 10.67T |
HOYA Corporation | 6,959.03B |
Takeda Pharmaceutical Company | 6,685.33B |
Daiichi Sankyo Company | 6,098.85B |
Otsuka Holdings | 4,093.02B |
Terumo | 3,564.47B |
Astellas Pharma | 2,865.39B |
Shionogi & | 2,200.22B |